Feature | January 09, 2014

FDA Clears Topera’s Third-Generation 3D Mapping System

System identifies sources that sustain complex cardiac arrhythmias

topera 3-d 3d mapping system firmap rhythmview EP lab mapping fibrillation
January 9, 2014 — Topera Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for the latest generation of its 3D Mapping System. The workstation will be exhibited Jan. 9-11 at the Boston AF Symposium 2014 in Orlando, Fla.
 
The Topera 3D Mapping System consists of the RhythmView Workstation and FIRMap diagnostic catheter.
 
The system provides near-instantaneous intra-procedural mapping and re-mapping capabilities. In addition, the system incorporates a new color-imaging module to aid identification of rotors, an electrophysiological phenomenon previously shown to sustain atrial fibrillation (AF). These functionalities enable EPs to more efficiently diagnose complex arrhythmias.
 
“Atrial fibrillation is an incredibly challenging arrhythmia to treat, and the complexity of this disorder has defied interpretation and visualization by traditional EP mapping approaches,” said Eric Prystowsky, M.D., director of clinical electrophysiology, St. Vincent Hospital, Indianapolis. “Topera’s technology is the first to demonstrate an ability to reflect faithfully the complex mechanism(s) of this arrhythmia and provide a reliable way to visualize the tissue sources sustaining it.”
 
In addition to FDA 510(k) clearance for Topera’s 3D Mapping System, the company also obtained regulatory clearances and launched its proprietary FIRMap panoramic contact-mapping basket catheter in the United States and Europe in late 2013. FIRMap is the first and only contact-mapping basket catheter cleared by the FDA for use in all cardiac chambers to assist in the diagnosis of complex arrhythmias.
 
For more information: www.toperamedical.com, afsymposium.com

Related Content

The Philips KODEX-EPD EP Mapping System Has New Imaging and Workflow Enhancements to aid electrophysiologists improve atrial fibrillation ablations.
News | EP Mapping and Imaging Systems | September 14, 2020
September 14, 2020 — Philips Healthcare released new imaging and workflow enhancements for its novel Kodex-EPD cardia
News | EP Mapping and Imaging Systems | August 17, 2020
August 17, 2020 — A Northwestern Medicine Bluhm Cardiovascular Institute physician was the first electrophyiologist i
Kardium Announces Successful Results From GLOBAL-AF Study
News | EP Mapping and Imaging Systems | October 15, 2019
October 15, 2019 — Kardium Inc.
Acutus Medical and Innovative Health Collaborate to Increase Patient Access to Electrophysiology Care
News | EP Mapping and Imaging Systems | October 09, 2019
Acutus Medical and Innovative Health announced a partnership that will offer advanced electrophysiology technology to...
Computer Simulations May Treat Most Common Heart Rhythm Disorder

The OPTIMA (Optimal Target Identification via Modelling of Arrhythmogenesis) simulator uses contrast-enhanced MRI scans to create personalized digital replicas of a patient's heart to guide catheter abation for atrial fibrillation. Image courtesy of Patrick M. Boyle and Natalia A. Trayanova.

News | EP Mapping and Imaging Systems | August 19, 2019
Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper chambers of the heart...
Charge Density Mapping Eliminates Repeat Ablation for Atrial Fibrillation at One Year
News | EP Mapping and Imaging Systems | July 15, 2019
Acutus Medical announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and Electrophysiology. The...
Innovative Health Receives FDA Clearance to Reprocess Pentaray Nav Eco High-density Mapping Catheter
News | EP Mapping and Imaging Systems | July 05, 2019
Single-use cardiology medical device reprocessing company Innovative Health, received U.S. Food and Drug Administration...
VIVO 3-D Cardiac Mapping System Cleared by FDA
Technology | EP Mapping and Imaging Systems | July 01, 2019
Catheter Precision Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared its new VIVO (View into...
Algorithm Steers Catheters to Right Spot to Treat Atrial Fibrillation

Using human AFib simulations, the researchers demonstrated that their technique can stop the catheter at the right target and identify the source type with a 95.25 percent success rate. This new algorithm also is effective in scarred tissue, which makes ablation more challenging, and has a 99 percent detection rate regardless of the scar size. Image courtesy of Florida Atlantic University.

News | EP Mapping and Imaging Systems | May 28, 2019
Researchers have developed the first algorithm that can locate patient-specific ablation targets for atrial...